SGW

Device To Detect Antibodies To Hepatitis D Virus

Product code
SGW
Device name
Device To Detect Antibodies To Hepatitis D Virus
Device class
Class 2
21 CFR
21 CFR 866.3176
Medical specialty
Immunology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

The device to detect antibodies to hepatitis D Virus is an in vitro diagnostic device intended for prescription use for the detection of antibodies to the hepatitis D virus (anti-HDV) in human clinical specimens. The assay is intended as an aid in the diagnosis of HDV infection in individuals who are at risk for HDV infection. The assay is intended as an aid in diagnosis in conjunction with clinical findings and other diagnostic procedures. The assay is not intended for screening of blood, plasma, cells, or tissue donors.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2025-12-23.

NumberDecision dateApplicantDevice nameSummary
DEN2500322025-12-23DiaSorin, Inc.LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUR…
Official FDA classification page: SGW
Classification and pathway per current FDA publications. Data from openFDA (CC0).